J. M. Blondeau, X. Zhao, G. Hansen, and K. Drlica, Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of Streptococcus pneumoniae, Antimicrobial Agents and Chemotherapy, vol.45, issue.2, pp.433-441, 2001.
DOI : 10.1128/AAC.45.2.433-438.2001

Y. Dong, X. Zhao, B. N. Kreiswirth, and K. Drlica, Mutant Prevention Concentration as a Measure of Antibiotic Potency: Studies with Clinical Isolates of Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.44, issue.9, pp.2581-2585, 2000.
DOI : 10.1128/AAC.44.9.2581-2584.2000

A. A. Firsov, D. Saverino, M. Ruble, D. Gilbert, B. Manzano et al., Predictors of effect of ampicillin-sulbactam against TEM- 1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC, Antimicrob Agents Chemother, vol.40, pp.734-742, 1996.

A. A. Firsov, S. N. Vostrov, O. V. Kononenko, S. H. Zinner, and Y. A. Portnoy, Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model, Antimicrob Agents Chemother, vol.43, pp.498-502, 1999.

A. A. Firsov, S. N. Vostrov, I. Y. Lubenko, K. Drlica, Y. A. Portnoy et al., In Vitro Pharmacodynamic Evaluation of the Mutant Selection Window Hypothesis Using Four Fluoroquinolones against Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, vol.47, issue.5, pp.1604-1617, 2003.
DOI : 10.1128/AAC.47.5.1604-1613.2003

L. L. Marcusson, S. K. Olofsson, P. Komp-lindgren, O. Cars, and D. Hughes, Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli, Journal of Antimicrobial Chemotherapy, vol.55, issue.6, pp.938-981, 2005.
DOI : 10.1093/jac/dki136

S. Mizunaga, T. Kamiyama, Y. Fukuda, M. Takahata, and J. Mitsuyama, Influence of inoculum size of Staphylococcus aureus and Pseudomonas, 2005.